发明授权
US07563798B2 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
有权
取代的吡唑并[1,5-a]嘧啶作为蛋白激酶抑制剂
- 专利标题: Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
- 专利标题(中): 取代的吡唑并[1,5-a]嘧啶作为蛋白激酶抑制剂
-
申请号: US11543182申请日: 2006-10-04
-
公开(公告)号: US07563798B2公开(公告)日: 2009-07-21
- 发明人: Timothy J. Guzi , Kamil Paruch , Michael P. Dwyer , M. Arshad Siddiqui , Panduranga Adulla P. Reddy , David B. Belanger , Blake Hamann , Patrick J. Curran
- 申请人: Timothy J. Guzi , Kamil Paruch , Michael P. Dwyer , M. Arshad Siddiqui , Panduranga Adulla P. Reddy , David B. Belanger , Blake Hamann , Patrick J. Curran
- 申请人地址: US NJ Kenilworth
- 专利权人: Schering Corporation
- 当前专利权人: Schering Corporation
- 当前专利权人地址: US NJ Kenilworth
- 代理商 Palaiyur S. Kalyanaraman
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; C07D487/04 ; A61P35/04
摘要:
In its many embodiments, the present invention provides a class of pyrazolo [1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases (CDKs), methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. An illustrative compound of the invention is shown below:
公开/授权文献
信息查询
IPC分类: